| Page 1952 | Kisaco Research
 

Malcolm Pye

CEO
Benchmark Holdings Plc

Malcolm has over 30 years’ experience in international agribusiness through his roles within the Hillsdown Holdings / HMTF group, operating in animal breeding, poultry, feed milling and veterinary services. During this time, Malcolm gained extensive experience in breeding and genetics, sales and strategic M&A, and held board positions within the Group. In 2000, Malcolm founded Benchmark, along with Roland Bonney and Ruth Layton, and has since led the Company’s growth and diversification. Malcolm has a degree in Zoology / Applied Zoology from the University of Wales (Bangor)

Malcolm Pye

CEO
Benchmark Holdings Plc

Malcolm Pye

CEO
Benchmark Holdings Plc

Malcolm has over 30 years’ experience in international agribusiness through his roles within the Hillsdown Holdings / HMTF group, operating in animal breeding, poultry, feed milling and veterinary services. During this time, Malcolm gained extensive experience in breeding and genetics, sales and strategic M&A, and held board positions within the Group. In 2000, Malcolm founded Benchmark, along with Roland Bonney and Ruth Layton, and has since led the Company’s growth and diversification. Malcolm has a degree in Zoology / Applied Zoology from the University of Wales (Bangor)

 

Gorjan Nikolik

Associate Director Animal Protein/Seafood
RaboResearch Food & Agribusiness

Since joining Rabobank in 2005, Gorjan Nikolik has been a Senior Analyst focusing on the global seafood sector including aquaculture, wild-catch, seafood trade and processing.

Gorjan Nikolik

Associate Director Animal Protein/Seafood
RaboResearch Food & Agribusiness

Gorjan Nikolik

Associate Director Animal Protein/Seafood
RaboResearch Food & Agribusiness

Since joining Rabobank in 2005, Gorjan Nikolik has been a Senior Analyst focusing on the global seafood sector including aquaculture, wild-catch, seafood trade and processing.

In his primary role, he works as a sector expert to Rabobank departments such as Mergers & Acquisitions, Leveraged Finance, Venture Capital, Credit Risk Management and the Corporate Finance Bankers. He is a regular speaker on global seafood and aquaculture conferences and has published research reports covering the seafood industry. He also has experience as a commodity analyst having covered the sugar industry. 

Gorjan holds a masters degree in Finance and Business Administration from the University of Maastricht and an MBA from Maastricht School of Management.

 

 

Prof. Ross Houston

Personal Chair of Aquaculture Genetics, The Roslin Institute
University of Edinburgh

Dr Houston’s research is primarily aimed at producing salmon offspring which will be less likely to catch diseases or infection. This is done by looking at the genes of salmon which have contracted these deficiencies and identifying the difference between them and the genes of those which did not. From this genetic data, you can now see which salmon will be resistant, and which will not.

Prof. Ross Houston

Personal Chair of Aquaculture Genetics, The Roslin Institute
University of Edinburgh

Prof. Ross Houston

Personal Chair of Aquaculture Genetics, The Roslin Institute
University of Edinburgh

Dr Houston’s research is primarily aimed at producing salmon offspring which will be less likely to catch diseases or infection. This is done by looking at the genes of salmon which have contracted these deficiencies and identifying the difference between them and the genes of those which did not. From this genetic data, you can now see which salmon will be resistant, and which will not.

Fish with resistant genes can be chosen and bred with one another, hopefully removing the likelihood of their offspring contracting diseases. These fish are then hatched into a fresh water hatchery, and moved to a salt water farming location after one year. These fish should be less likely to contract diseases, infections or sea lice, a trait they should pass on to their offspring. 

There is no genetic manipulation in this process; it is a selective breeding process which uses genetic research to produce salmon which are more likely to survive in fish farms, and can result in higher quality fillets for consumers.

Dr Houston’s research has had a positive impact in many areas.

 

Geir Bjarne Myre

Global Product Manager of Aquaculture Insurance
XL Catlin

Geir Bjarne Myre

Global Product Manager of Aquaculture Insurance
XL Catlin

Geir Bjarne Myre

Global Product Manager of Aquaculture Insurance
XL Catlin
 

Heather Roxborough

Senior Director of New Ventures & Transactions
Johnson & Johnson Innovation London

Heather Roxborough

Senior Director of New Ventures & Transactions
Johnson & Johnson Innovation London

Heather Roxborough

Senior Director of New Ventures & Transactions
Johnson & Johnson Innovation London
 
17-18 Sep 2019
COMPUTER HISTORY MUSEUM, MOUNTAIN VIEW, CA
Take advantage of over 9 hours of dedicated networking time to meet key industry leaders, whilst also exploring:  Luminary Keynotes: Unique perspectives from industry luminaries in hardware (John Hennessy), AI (TBC) and investment (Lip-Bu Tan).Innovations and Optimizations of Silicon & Systems for AI Training & Inference: Presentations and product launches from C-level executives from AI chip start ups, semiconductor companies and systems OEMs.Training & Inference at Hyperscale & AI Accelerators in the Data Center Hardware Environment: Deployment & maintenance of AI infrastructure in data centers, hardware requirements for training & inference at scale.Inference in Client (Edge) Computing: Applications for AI accelerators in cameras, consumer electronics, autonomous vehicles etc.Beyond Compute: AI’s Impact on Memory, Storage & Networking: Innovations in HBM, on-chip memory and NVM, I/O bottlenecks, data transfer & high-speed interconnects.The Impact of Future ML Models on Hardware Design: Machine Learning co-design, robustness & reprogrammability, model standardization & interoperability.AI Chip Design & Commercialization: Design, testing & manufacturing, form factors & routes-to-market.Financial & Industrial Analysis: Market growth and maturity, VC investment trends & dynamics, the commoditization of the inference market, benchmarking & metrics.“Two overarching efforts are indispensable in this AI chip development frenzy: objectively evaluating and comparing different chips (benchmarking), and reliably projecting the growth paths of AI chips (road mapping).” White Paper on AI Chip Technologies: Tsing Hua University & Beijing Innovation Center for Future Chips, December 2018.
 
14-15 Nov 2018
London, United Kingdom
SKIN MICROBIOME IS SET TO REVOLUTIONISE DERMATOLOGYWith the European cosmetics industry playing a leading role in science-driven product development and innovation in skincare, we are proud to announce that we are bringing the Skin Microbiome Congress to London, following the success of our sold out inaugural event in Boston.As new clinical data transpires to support the role of the skin microbiome in common conditions from acne and eczema to dandruff and skin allergies, Pharmaceutical Researchers and Cosmetic Formulators alike are turning their attention to designing and testing products that contain live bacteria, bacterial extracts or prebiotic and postbiotic ingredients to manipulate the skins microbiota.The European Skin Microbiome Congress will bring together leaders from pharmaceutical, therapeutics and cosmetics industries, to showcase:• Cutting edge research• New therapeutic & cosmetic advances• Consumer trends & insights• Regulatory considerationsJoin 200+ industry leaders to explore the different pathways market and how to translate therapeutic research into commercially viable cosmetic products.View highlights from the inaugural SOLD OUT Skin Microbiome Congress, May 30-31, 2018Discover the potential of prebiotic, probiotic and postbiotic products being developed to protect and promote a healthy microbiome and ultimately combat dermatological conditions from acne and eczema to dandruff and skin allergies. Take advantage of: Effective Networking - Pre-schedule private meetings with any individual or company onsite using the online meeting scheduler applicationCutting Edge Research – Discover the latest advancement in therapeutic & cosmetic products containing live bacteria, bacterial extracts, or active ingredients to promote & protect the skins microbiomeConsumer Trends - Understand how consumers trends towards natural, organic products and active beauty are shaping the evolution of products adapted to the skin microbiomeClinical Trials – Explore how to design an effective clinical trial & translate research into clinically & commercially viable therapeuticsCompetitive Edge – Determine how to differentiate your product line & seize this market opportunity, gaining market share with scientifically backed productsRegulation – Understand the different paths to market & regulatory considerations necessary to launch a cosmetic or therapeutic productWith an increasing consumer trend towards natural products, what’s more natural than harnessing the bacteria on your skin? Don't miss your chance to understand the next generation of natural skincare products!
 
Skin Microbiome Westcoast 2018
12-13 Sep 2018
San Francisco, CA
The average consumer spends $5 a day on skincare, whilst using up to 515 synthetic chemicals daily to eradicate dermalogical concerns - how can this be good for skin? Introducing the Skin Microbiome Congress.Following the mainstream focus on the gut microbiome and its role in health and disease, researchers and industry experts are now turning their attention towards the emerging relationship between the skin microbiome and healthy skin. This has the potential to revolutionise the beauty and personal care industry.View highlights from the inaugural Skin Microbiome Congress, May 30-31, 2018Join 200+ industry experts from multinational pharmaceutical, beauty and personal care companies, along with the independent skincare brands and innovative biotechs who are advancing the field.Discover the potential of prebiotic, probiotic and postbiotic products being developed to protect and promote a healthy microbiome and ultimately combat dermatological conditions from acne and eczema to dandruff and skin allergies. Take advantage of: Effective Networking - Pre-schedule private meetings with any individual or company onsite using the online meeting scheduler applicationCutting Edge Research – Discover the latest advancement in therapeutic & cosmetic products containing live bacteria, bacterial extracts, or active ingredients to promote & protect the skins microbiomeConsumer Trends - Understand how consumers trends towards natural, organic products and active beauty are shaping the evolution of products adapted to the skin microbiomeClinical Trials – Explore how to design an effective clinical trial & translate research into clinically & commercially viable therapeuticsCompetitive Edge – Determine how to differentiate your product line & seize this market opportunity, gaining market share with scientifically backed productsRegulation – Understand the different paths to market & regulatory considerations necessary to launch a cosmetic or therapeutic productWith an increasing consumer trend towards natural products, what’s more natural than harnessing the bacteria on your skin? Don't miss your chance to understand the next generation of natural skincare products!